Wnt-001

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameWnt-001
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionLow-density lipoprotein receptor-related protein 6 inhibitors
TargetsLow-density lipoprotein receptor-related protein 6
Therapy Area/IndicationsFibrosisEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWntgen LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWntgen LLC
Active IndicationsN/A
Inactive IndicationsFibrosisEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A